N/A
N=7
Evaluation of Pancreatobiliary Disorders in Patients With Altered Gastric Anatomy
Pancreatobiliary Disease · Altered Gastric Anatomy
Bottom Line
View on ClinicalTrials.gov: NCT01238341 ↗Enrolled (actual)
7
Serious AEs
0.0%
Results posted
Oct 2015
Primary outcome: Primary: Papilla or Duct-enterostomy Was Reached — 10 ERCPs
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Endoscopic Retrograde Cholangiopancreatography (ERCP) (Procedure)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Florida
- Primary completion
- Jul 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Papilla or Duct-enterostomy Was Reached |
10 | — |
| SECONDARY Successful Cannulation of the Duct of Intent |
8 | — |
| SECONDARY Successful Endoscopic Therapy |
9 | — |
| SECONDARY Total Procedure Time |
95.6 | — |
Summary
In patients, who have altered gastric anatomy and pancreatobiliary disease, the use of an endoscopic overtube to facilitate an Endoscopic Retrograde Cholangiopancreatography (ERCP).
Eligibility Criteria
Inclusion Criteria
- Subject is 18 years or older
- Subject has medical indication for Endoscopic Retrograde Cholangiopancreatography (ERCP)
- Subject has altered gastric anatomy
- Subject must be able to give informed consent.
Exclusion Criteria
- Any contraindication for Endoscopic Retrograde Cholangiopancreatography (ERCP) with overtube
- The subject is unable to give informed consent
Data sourced from ClinicalTrials.gov (NCT01238341). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.